Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
            (Q58023953)
        
    
                
                
article
            
    article
                    Language:
                    
                    
                
            
            
                Current Data About 
    
        
            
    Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
        
    
            
        
        
            
                other details